← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksASBPWRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

ASBPW logoAspire Biopharma Holdings, Inc. (ASBPW) Revenue History

Annual and quarterly revenue from 2022 to 2024

TTM Revenue
$2K
0
YoY Growth
-
Latest Quarter
$2K
Q3 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$2K (Q3 2025)
Revenue per Share$0.00

Loading revenue history...

Revenue Growth Metrics

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Revenue per Share$0.00
Peak Annual Revenue$0 (0)

Download Historical Data

3 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ASBPW Revenue Analysis (2022–2024)

As of March 5, 2026, Aspire Biopharma Holdings, Inc. (ASBPW) generated trailing twelve-month (TTM) revenue of $1,941. The most recent quarter (Q3 2025) recorded $1,941 in revenue.

Looking at the longer-term picture, ASBPW's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including CAI (+144.9% YoY), VCYT (+16.0% YoY), and ADPT (+42.6% YoY). Compare ASBPW vs CAI →

Peer Comparison

Compare ASBPW's revenue metrics with industry peers

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
ASBPW logoASBPWCurrent$1,941---
CAI logoCAI$812M+144.9%+14.3%5.6%
VCYT logoVCYT$517M+16.0%+34.5%11.2%
ADPT logoADPT$179M+42.6%+16.0%-90.8%
CDIO logoCDIO$34,890-55.8%--23977.9%
SEER logoSEER$14M+14.5%+160.6%-717.7%
Best in groupLowest in group

Historical Revenue Data

Showing 3 of 3 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$0-$0-$-3,088,671-
2023$0-$0-$-1,340,168-
2022$0-$0-$-976,345-

See ASBPW's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ASBPW Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare ASBPW vs LLY

See how ASBPW stacks up against sector leader Eli Lilly and Company.

Start Comparison

Frequently Asked Questions

Is ASBPW's revenue growth accelerating or slowing?

ASBPW TTM revenue: $1941.00. YoY growth: N/A. 5-year CAGR: N/A.

What is ASBPW's long-term revenue growth rate?

Aspire Biopharma Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is ASBPW's revenue distributed by segment?

ASBPW reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.

Revenue Over Time